Lista de obras -

Antibodies against Anthrax: Mechanisms of Action and Clinical Applications ⬇️

artículo científico publicado el 16 de noviembre de 2011

Antibodies for biodefense

artículo científico publicado en 2011

Detection of antiranibizumab antibodies among patients with exudative age-related macular degeneration

artículo científico publicado en 2014

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E

artículo científico publicado en 2015

Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin

artículo científico publicado en 2016

Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B

artículo científico publicado en 2015

Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.

scientific article published on 09 January 2014

Effect of formulation on the stability and aerosol performance of a nebulized antibody

artículo científico publicado en 2014

High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation

artículo científico publicado en 2007

Human-like antibodies neutralizing Western equine encephalitis virus

artículo científico publicado en 2014

Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus

artículo científico publicado en 2009

Improvement of an antibody neutralizing the anthrax toxin by simultaneous mutagenesis of its six hypervariable loops.

artículo científico publicado en 2008

Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo

artículo científico publicado en 2012

Isolation of Antibodies From Non-Human Primates for Clinical Use ⬇️

artículo científico publicado el 1 de marzo de 2014

Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity

artículo científico publicado en 2009

Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin

artículo científico publicado en 2011

Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain

artículo científico publicado en 2015

Mapping the Epitopes of a Neutralizing Antibody Fragment Directed against the Lethal Factor of Bacillus anthracis and Cross-Reacting with the Homologous Edema Factor ⬇️

artículo científico publicado el 31 de mayo de 2013

Obtention and engineering of non-human primate (NHP) antibodies for therapeutics.

artículo científico publicado en 2009

Structural differences of amyloid-β fibrils revealed by antibodies from phage display

artículo científico publicado en 2015

[Recombinant antibodies for medical protection against bioterrorism agents: the example of anthrax]

artículo científico publicado en 2010

Lista de obras de

Antibodies against Anthrax: Mechanisms of Action and Clinical Applications ⬇️

Antibodies for biodefense

Detection of antiranibizumab antibodies among patients with exudative age-related macular degeneration

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E

Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin

Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B

Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.

Effect of formulation on the stability and aerosol performance of a nebulized antibody

High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation

Human-like antibodies neutralizing Western equine encephalitis virus

Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus

Improvement of an antibody neutralizing the anthrax toxin by simultaneous mutagenesis of its six hypervariable loops.

Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo

Isolation of Antibodies From Non-Human Primates for Clinical Use ⬇️

Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity

Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin

Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain

Mapping the Epitopes of a Neutralizing Antibody Fragment Directed against the Lethal Factor of Bacillus anthracis and Cross-Reacting with the Homologous Edema Factor ⬇️

Obtention and engineering of non-human primate (NHP) antibodies for therapeutics.

Structural differences of amyloid-β fibrils revealed by antibodies from phage display

[Recombinant antibodies for medical protection against bioterrorism agents: the example of anthrax]